As readers of this blog know, we have been following the proposed Pharmaceutical Market Access and Drug Safety Act carefully as it wends its way through Congress. So far, neither the House nor Senate versions of the bill have gotten very far since their introduction in early March, although there has been some talk that the Senate bill may be put to a vote within a matter of weeks.
For those of you who would like to learn more about this proposed legislation, which would allow American consumers to legally purchase prescription drugs from Canada and other Tier One countries, you can read the full text of the House bill here, and a summary here.
Why do we need this legislation passed? The bill makes the case in seven points:
And what would passage of the bill achieve? Here’s a summary:
Pharmaceutical Market Access and Drug Safety Act of 2009 – Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.
Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.
Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.
Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.
Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.
States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.
Requires the Secretary to educate consumers regarding prescription drug importation.
Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.
Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.
We wholeheartedly support the Pharmaceutical Market Access and Drug Safety Act, and we encourage you to contact your Congressman and Senator to show your support as well.
-
-
-
How to Safely Buy Prescription Drugs Online from Cary Byrd on Vimeo.
-
Search Blog Posts
-
Trending Content
-
Blogroll
- Bullet Wisdom
- Christian Social Network
- DrugWonks.com
- Eye on FDA
- GoozNews
- Health 2.0
- In the Pipeline
- Jesus Christ Our King
- Kevin, M.D.
- Pharm Aid
- Pharma Marketing
- PharmaGossip
- Pharmalot
- San Antonio Asphalt
- San Antonio Life Insurance
- San Antonio Pressure Washing
- The Angry Pharmacist
- The Health Care Blog
- The Peter Rost Blog
- World Vision
-
Tags
big pharma Canadian drugs canadian pharmacies canadian pharmacy consumer reports craig newmark divine healing Drug costs drug prices Drug reimportation eDrugSearch.com FDA Fosamax Generic drugs healing scriptures Health 2.0 healthcare reform Hypertension Jehova Rophe Jesus Christ Lipitor Metformin miracles nabp online pharmacy dictionary online prescriptions osteoporosis peter rost Pharmacies pharmacists pharmacychecker pharmacy spam phrma Prescription drug coupons Prescription drugs prescription medication Proverbs 3:5-8 reimportation relenza Roche saving money swine flu Tamiflu The Great Physician The Lord our Healer -
Archives
- July 2013 (10)
- June 2013 (8)
- May 2013 (8)
- April 2013 (8)
- March 2013 (10)
- February 2013 (14)
- January 2013 (6)
- August 2012 (2)
- July 2012 (1)
- June 2012 (1)
- April 2012 (6)
- March 2012 (3)
- February 2012 (1)
- January 2012 (2)
- November 2011 (2)
- June 2011 (2)
- August 2010 (1)
- July 2010 (2)
- June 2010 (2)
- May 2010 (3)
- April 2010 (4)
- March 2010 (5)
- February 2010 (4)
- January 2010 (1)
- November 2009 (2)
- October 2009 (6)
- September 2009 (7)
- August 2009 (11)
- July 2009 (12)
- June 2009 (18)
- May 2009 (14)
- April 2009 (10)
- March 2009 (13)
- February 2009 (10)
- January 2009 (10)
- December 2008 (24)
- November 2008 (22)
- October 2008 (27)
- September 2008 (28)
- August 2008 (23)
- July 2008 (30)
- June 2008 (32)
- May 2008 (29)
- April 2008 (27)
- March 2008 (19)
- February 2008 (26)
- January 2008 (35)
- December 2007 (23)
- November 2007 (26)
- October 2007 (36)
- September 2007 (25)
- August 2007 (33)
- July 2007 (36)
- June 2007 (31)
- May 2007 (32)
- April 2007 (22)
- March 2007 (22)
- February 2007 (29)
- January 2007 (18)
- December 2006 (56)
- November 2006 (16)
-
Recent Comments
- Sophie on Reclast’s “jaw problems” caused by too many warnings, spoken too quickly?
- Marcy on How to Get Coupons on Prescription Drugs
- Cary Byrd on Maine Becomes First State to Allow Prescription Drug Importation from Licensed Mail-Order Pharmacies
- brenda eppinette on Maine Becomes First State to Allow Prescription Drug Importation from Licensed Mail-Order Pharmacies
- Ranee on What is the Difference Between Effexor and Cymbalta?